Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 4, 1997, Pages 215-222

  Markiewicz, Leszek ^a   Gurpide, Erlio ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alkaline phosphatase; Androgens; Estrogenic activities; Human cancer cell lines; In vitro bioassays; Progestagenic activities

Indexed keywords

11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1 PROPYNYL)ESTRA 4,9 DIEN 3 ONE; 4 HYDROXYTAMOXIFEN; ALKALINE PHOSPHATASE; ANDROGEN; ANDROSTANOLONE; CYPROTERONE ACETATE; ESTROGEN; ESTROGEN RECEPTOR; HYDROXYFLUTAMIDE; MIBOLERONE; MIFEPRISTONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NANDROLONE; NANDROLONE DERIVATIVE; ONAPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; TESTOSTERONE;

ARTICLE; BIOASSAY; BREAST CANCER; CARCINOMA CELL; DRUG ANTAGONISM; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; ESTROGEN ACTIVITY; HORMONE ACTION; HUMAN; HUMAN CELL;

ADENOCARCINOMA; ALKALINE PHOSPHATASE; ANDROGEN ANTAGONISTS; ANDROGENS; BREAST NEOPLASMS; CYPROTERONE ACETATE; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; FLUTAMIDE; GONANES; HUMANS; MIFEPRISTONE; POLYUNSATURATED ALKAMIDES; PROGESTINS; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE CONGENERS; TUMOR CELLS, CULTURED;

EID: 0030790933     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ruh, T.S., Ruh, M.F. Androgen induction of a specific uterine protein. Endocrinology 1975, 97: 1144-50.
2. Hori, S.H., Kodama, T., Tanahashi, K. Induction of vitellogenin synthesis in goldfish by massive doses of androgen. Gen Comp Endocrinol 1979, 37: 306-20.
3. Pelissero, C., Flouriot. G., Foucher, J.L. et al. Vitellogenin synthesis in cultured hepatocytes: An in vitro test for the estrogenic potency of chemicals. J Steroid Biochem Mol Biol 1993, 44: 263-72.
4. Lieberman, M.E., Maurer, R.A., Gorski, J. Estrogen control of prolactin synthesis in vitro. Proc Natl Acad Sci USA 1978, 75: 5946-9.
5. Holinka, C.F., Hata, H., Kuramoto, H., Gurpide, E. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cells (Ishikawa line). Cancer Res 1986, 46: 2771-4.
6. Nishida, M., Kasahara, K., Kaneka, M., Iwasaki, H. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynecol Jpn 1985, 37: 1103-11.
7. 2a output by human endometrium in vitro. Am J Obstet Gynecol 1988, 159: 500-4.
8. Di Lorenzo, D., Albertini, A., Zava, D. Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D. Cancer Res 1991, 51: 4470-5.
9. Littlefield, B.A., Gurpide, E., Markiewicz, L., McKinley, B., Hochberg, R.B. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: Estrogenic action of Δ 5 adrenal steroids. Endocrinology 1990, 127: 2757-62.
10. Markiewiez, L., Hochberg, R.B., Gurpide, E. Intrinsic estrogenicity of some progestagenic drugs. J Steroid Biochem Mol Biol 1992, 41: 53-8.
11. Markiewicz, L., Gurpide, E. In vitro bioassays for drugs with dual estrogenic and progestagenic activities. Ann NY Acad Sci 1994, 734: 285-91.
12. Markiewicz, L., Gurpide, E. Estrogenic and progestagenic activities coexisting in steroidal drugs: Quantitative evaluation by in vitro bioassays with human cells. J Steroid Biochem Mol Biol 1994, 48: 89-94.
13. Traish, A.M., Muller, R.E., Wotiz, H.H. Binding of 7a,17a-dimethyl-19-nortestosterone (mibolerone) to undrogen and progesterone receptors in human and animal tissues. Endocrinology 1986, 118: 1327-33.
14. Di Sorbo, D., Rosen, F., McPartland, R.P., Milholland, R.J. Glucocorticoid activity of various progesterone analogs: Correlation between specific binding in thymus and liver and biologic activity. Ann NY Acad Sci 1977, 286: 335-66.
15. Chobert, M.N., Barouki, R., Findori, J. et al. Antiglucorticoid properties of RU 38486 in a differentiated hepatoma cell line. Biochem Pharmacol 1983, 32: 3481-3.
16. Kuttenn, F., Rigaud, C., Wright, F., Mauvais-Jarvis, P. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol. J Clin Endocrinol Metab 1980, 51: 1107-11.
17. Guthrie, G.P. Jr., John, W.J. In vitro glucocorticoid and antiglucocorticoid action of medroxyprogesterone acetate. Endocrinology 1980, 107: 1393-6.
18. Bardon, S., Vignon, F., Chalbos, D., Rochefort, H. RU 486, a progestin and glucocorticoid antagonist inhibits the growth of breast cancer cells via the progesterone receptor. J Clin Endocrinol Metab 1985, 60: 692-7.
19. Jeng, M.-H., Langan-Fahey, S.M., Jordan, V.C. Estrogenic action of RU 486 in hormone-responsive MCF-7 human breast cancer cells. Endocrinology 1993, 132: 2622-30.